CD274 and neuroblastoma: The lack of effects of anti-PD-L1 or anti-PD-1 mAb mono-therapy in our NB model does not seem related to differences in the type or dosage of mAb used, since the mAb clone and the doses are the same reported to be successful in other experimental models31.